Cancer Sciences, University of Southampton, Southampton, UK.
Support Care Cancer. 2013 Sep;21(9):2625-36. doi: 10.1007/s00520-013-1881-9. Epub 2013 Jun 25.
Assessing the health-related quality of life (HRQOL) of cancer patients with cachexia is particularly important because treatments for cachexia are currently aimed at palliation and treatment efficacy must be measured in ways other than survival. The aim of this systematic review was to evaluate HRQOL assessment in cancer patients with cachexia.
Using guidance from the Centre for Reviews and Dissemination, relevant databases were searched from January 1980 to January 2012 with terms relating to cancer, cachexia and HRQOL for papers including adult cancer patients with cachexia or documented weight loss at baseline.
We found one cachexia-specific instrument, the Functional Assessment of Anorexia/Cachexia Therapy, but the tool has not been fully validated, does not cover all the relevant domains and the consensus-based standards for the selection of health status measurement instruments checklist highlighted a number of weaknesses in the methodological quality of the validation study. Sixty-seven studies assessed HRQOL in cachectic or weight-losing cancer patients. Most used generic cancer HRQOL instruments, limiting the amount of useful information they provide. A modified version of the Efficace minimum data checklist demonstrated that the quality of reporting on HRQOL tool use was inadequate in many of the studies. A negative relationship between HRQOL and weight loss was found in 23 of the 27 studies which directly examined this.
There is a pressing need for a well-designed HRQOL tool for use with this patient group in both clinical trials and clinical practice.
评估恶病质癌症患者的健康相关生活质量(HRQOL)尤为重要,因为目前恶病质的治疗方法主要是姑息治疗,必须通过其他方法来衡量治疗效果,而不仅仅是生存。本系统评价的目的是评估患有恶病质的癌症患者的 HRQOL 评估方法。
根据考科蓝中心(Centre for Reviews and Dissemination)的指导,我们从 1980 年 1 月至 2012 年 1 月,使用与癌症、恶病质和 HRQOL 相关的术语,检索相关数据库,纳入包含基线时患有恶病质或有体重下降记录的成年癌症患者的论文。
我们发现了一种专门用于恶病质的工具,即厌食/恶病质治疗功能评估(Functional Assessment of Anorexia/Cachexia Therapy),但该工具尚未得到充分验证,未涵盖所有相关领域,共识为健康状况测量仪器选择标准强调了验证研究在方法学质量方面的许多弱点。67 项研究评估了恶病质或体重减轻的癌症患者的 HRQOL。大多数研究使用了一般性癌症 HRQOL 工具,限制了它们提供的有用信息的数量。Efficace 最低数据清单的修订版表明,在许多研究中,关于 HRQOL 工具使用的报告质量不足。在直接检查这一点的 27 项研究中的 23 项研究中,发现 HRQOL 与体重下降呈负相关。
迫切需要为这一患者群体设计一种设计良好的 HRQOL 工具,以便在临床试验和临床实践中使用。